Express Healthcare

‘Radiation in Healthcare Summit 2012′: Rooting for Nuclear power

0 67

Radiation in Healthcare Summit 2012′ was recently held on 27th September 2012 at the Bombay Convention and Exhibition Centre, Mumbai. Organised by UBM, the event was also supported by Department of Atomic Energy (DAE), the Board of Radiation and Isotope Technology (BRIT), The Society of Nuclear Medicine – India (SNMI), the Association of Medical Physicists of India (AMPI) and the Indian Association of Radiation Protection (IARP), premier agencies, working to promote the advancement of nuclear power and research in nuclear science and technology.

The Radiation in Healthcare Summit was co-located with India Nuclear Energy 2012, another event to showcase the rapidly growing civil nuclear energy sector. The Summit was an attempt to present the positive applications of nuclear energy and radiation, as well as to burst several myths about the so called harmful effects of radiation. The event also had an exhibition that showcased radiation-based equipment and services which are used for therapy and diagnosis in medical sciences.

The conference held at the summit covered several pertinent topics such as ‘Radiation in Cancer Treatment’, ‘Emerging trends in Clinical Nuclear Medicine diagnosis and treatment’, ‘R&D in Radiopharmaceuticals’, ‘Advances in Radiation therapy and Imaging’ etc. Some of the prominent speakers at the event were Prof MRA Pillai, Head, Radiopharmaceuticals Division, Bhabha Atomic Research Centre & Professor, Homi Bhabha National Institute (HBNI); Dr. Birajlaxmi Das, Bhabha Atomic Research Centre; Dr PK Pradhan, President, Society of Nuclear Medicine, India; Dr SK Shrivastava, Prof & Head, Department of Radiation Oncology, Tata Memorial Centre etc.

All of these speakers elucidated on the various advantages offered by nuclear energy and gave a wealth of information on the various applications of nuclear energy in the field of medicine. Presentations which demonstrated that, if used in moderation, radiation has no lasting harmful effects offered several learning lessons and served as real eye-openers.

CEOs, MDs, Directors, senior management, senior doctors and consultants from the medical and health institutes, radiotherapists, oncologists, nuclear medicine practitioners, medical schools, medical researchers, scientists, instrumentation researchers, biotechnology researchers, genetic engineers, and medical professionals were among the audience who attended the event.

- Advertisement -

Leave A Reply

Your email address will not be published.